Dr. Mohamad Moussa is an Associate Professor of Urology at the Lebanese University School of Medicine and also serves as the head of the urology department at Al Zahraa Hospital, University Medical Center at Beirut, Lebanon. He received his Medical Degree from the University of Padova in Italy. He completed his internship in surgery and residency in urology in Germany. He serves as the Vice president of the Lebanese society of urology. He is a member of several well-reputed and internationally-recognized associations; most notable of which are the American Urological Association (AUA), the European Association of Urology (EAU), German Association of urological surgeons, Société Internationale d'Urologie (SIU).
Dr. Moussa is an expert in oncological surgery having performed over 2,500 Radical cystectomy and prostatectomy surgeries. He is leading one of the best referral centers in the Middle East performing many complicated oncological and reconstructive surgeries.
Dr. Moussa’s primary focus is to lead the development of a comprehensive, multidisciplinary bladder cancer program. He organized an active unit in Pediatric Urology and another of endourology in his hospital.
Dr. Moussa is Chair of the Research Committee of Al Zahraa Hospital. He also runs a research laboratory aimed to use Stem cell therapy in the treatment of Peyronie disease. He has written many original peer-reviewed articles, along with numerous additional articles, editorials, relating to his oncological research and clinical activities.
Suks Minhas qualified from Sheffield Medical School in 1989 before completing specialist training at the Institute of Urology London. In 2003 he was appointed Consultant Urological Surgeon at University College London Hospital and then in 2018 became Consultant Urologist and Andrologist at Imperial College London. He also works closely with the Lister Fertility Clinic at the Lister Hospital, one of the largest fertility centres in the UK. During his training Suks was awarded the prestigious Karl Storz Telescope, an award given to specialists who have madea significant and lasting contribution to British Urology.
Whilst having a wealth of experience in general urology, Suks is widely regarded as an expert in Andrology specialising in treating problems associated with male genitals including male fertility, Peyronie’s disease, penile surgery and penile cancer. He is one of the few dedicated andrology surgeons in the UK and has earnt a reputation as a key international opinion leader within this field.
Suks has published extensively on the subject of andrology including papers, textbooks and chapters. He recently produced a textbook on Male Sexual Dysfunction. Suks is regularly invited to lecture around the world on the subject of andrology and chairs scientific meetings both nationally and internationally. He was appointed as Chairman of British Urological Surgeons Section of Andrology and is currently a board member of the European Society of Andrological Surgery. Suks enjoys cricket, reading and football when he is away from work.
Professor Piotr L. Chlosta, MD, PhD, DSci, FEBU, FRCS (Glasg.)
Professor of Urology and Chairman Department of Urology Jagiellonian University in Krakow. President Polish Urological Association.
Visiting Professor at the Centre of Postgraduate Medicine Education in Warsaw and lecturer at the School of Urology Committee of Education of the Polish Urological Association. Prof. Piotr Chlosta is member of several scientific associations, including the European Association of Urology, the American Urological Association (AUA), Academic Association of European Urologists, Laparoscopy Working Group at the EAU Section of Uro - Technology (ESUT) and the Societé Internationale d’Urologie. He is also a Board Member of ESOU. In addition, he is member of the National Examination in Urology Committee and former (2002 - 2013) delegate of the European Board of Urology. Honorary Member of Videosurgery Section Polish Surgeons Association, Hungarian Urological Association New Yoor Section of AUA and external assesor of the Athenian Medical University, Greece. Doctor honoris causa of Semmelweis Medical University in Budapest (Hungary).His main professional and scientific interests are urological oncology, laparoscopy and robotic surgery. P. Chlosta is author of several original and peer-reviewed articles, books, and book chapters.
Prof. Dr Serdar Tekgul FEAPU
Dr.Serdar Tekgul is Professor of Urology at Hacettepe University in Ankara. Following his urology training at Hacettepe University, he has had his Pediatric Urology training at University of Washington, Children’s Hospital with Dr.Micheal Mitchell in 1994-95. Since then he has limited all of his academic and clinical work to Pediatric Urology. He is currently chairing the section of Pediatric Urology at Hacettepe University, which is one of the accredited training programs for pediatric urology in Europe. His academic interests in different areas of pediatric urology are obstructive uropathy, voiding dysfunction, reflux, and reconstructive surgery of the bladder and childhood urolithiasis. He is actively involved in the administrative work for urology residency training programs. He has chaired the Turkish Board of Urology, Exam Committee 2002-2009. He has been the president of Turkish Pediatric Urology Association in 2007-2011. He is currently the President of Society of Urological Surgery in Turkey. He has more than 100 publications in peer view journals, made many presentations and he has been invited as lecturer in numerous International meetings for Pediatric Urology and has been visiting Professor in several pediatric urology centers around the world. He is a member of both Pediatric Urology Societies in Europe and in U.S. He is a member of Society of Pediatric Urological Surgeons (SPUS). He is a member of American Association of Genito-Urinary Surgeons ( AAGUS) .
He has been the organizer of several ESPU courses, 9th biannual ICCS meeting and 21st ESPU annual meeting. He has been one of the assistant editors of Journal of Pediatric Urology. He is in the editorial board of several international journals for urology and Pediatric Urology. He has been a member of the Children’s Committee for the International Consultation for Incontinence (ICI) in 2004 and 2008. He was the committee chair in 2008 in Paris. He is a member of the EAU guidelines committee and chairing the Pediatric Urology group since 2008. He is a faculty member of European School of Urology and has been lecturer in several ESU courses and annual EUREP course. He is board member of ESPU and has acted as the Chairman of Educational Committee for 6 years and the Scientific Secretary of the European Society for Pediatric Urology for 2 years. He served as the Secretary of ESPU between 2010 and 2018. He is currently a member of European Board of Urology executive committee and chairman of the examination committee.
Professor John D. Kelly
John Kelly is Professor of Uro-Oncology at University College London and Honorary Consultant Urologist at University College London Hospital. He is Head of the Department of Urology at UCLH and Director for robotic surgery at the Chitra Sethia Centre. UCLH is the UKs largest centre for robotic pelvic surgery, John Kelly has expertise in complex pelvic surgery and integrates high quality clinical activity with translational research. He is chief investigator for six multicentre randomised controlled trials (CRUK funded) and was Chair of the NCRI Bladder Cancer Clinical Study Group. He holds the Orchid Chair of Urology at Barts Hospital, Queen Mary University London.
John received his medical degree from The Queen’s University of Belfast. He was awarded The Professor Geoffrey D. Chisholm Prize, The Calvert Medal and the Ethicon Foundation Prize. He was a recipient a British Urological Foundation Award following which he completed a Fellowship at the New York Presbyterian Hospital – Weill Medical College of Cornell University, New York. He was a Senior Lecturer in Uro-Oncology at Cambridge University studying genomic alterations in cancer to identify novel alterations and key processes in tumourigenesis and leads a genomics research group investigating epigenetic and genomic alterations in bladder cancer which can be exploited to predict outcomes and detect disease.
Ο Πανελλήνιος Ιατρικός Σύλλογος, σύμφωνα με τα κριτήρια της UEMS- EACCME, θα χορηγήσει εώς 17 μόρια Συνεχιζόμενης Ιατρικής Εκπαίδευσης (CME-CPD) στους ιατρούς που θα παρακολουθήσουν την Επιστημονική Συνάντηση.
Το Συνέδριο θα πραγματοποιηθεί στην Αθήνα, στο Ξενοδοχείο Athenaeum Intercontinental
3 – 5 Ιουλίου 2020
Προσθήκη στο ημερολόγιο
Η επίσημη γλώσσα του Συνεδρίου είναι η Ελληνική. Οι ομιλίες των ξένων προσκεκλημένων θα γίνουν στα Αγγλικά, χωρίς διερμηνεία στα Ελληνικά.
Για να είστε ενημερωμένοι με τις τελευταίες εξελίξεις πριν, κατά τη διάρκεια και μετά τo Συνέδριο ακολουθήστε την σελίδα στο Facebook
Πατήστε εδώ για να δείτε το έγγραφο.
Παρατηρούνται διαρκώς αυξανόμενα περιστατικά με απόπειρες απάτης μέσω internet, email ακόμη και τηλεφώνου, από άτομα που ισχυρίζονται ότι επικοινωνούν εκ μέρους του επίσημου διοργανωτή του συνεδρίου.
|Παρατηρούνται διαρκώς αυξανόμενα περιστατικά με απόπειρες απάτης μέσω internet, email ακόμη και τηλεφώνου, από άτομα που ισχυρίζονται ότι επικοινωνούν εκ μέρους του επίσημου διοργανωτή του συνεδρίου. Η μοναδική (και επίσημη) ιστοσελίδα του συνεδρίου είναι η www.athenianurologydays.gr και η εταιρεία διοργάνωσης η Erasmus Conferences & Events S.A. Παρακαλούμε μην μοιράζεστε στοιχεία πιστωτικών καρτών ή άλλες εμπιστευτικές πληροφορίες αν δεν είστε απολύτως βέβαιοι ότι επικοινωνείτε με εκπρόσωπο της Erasmus Conferences & Events S.A. Σε περίπτωση που υποπέσει στην αντίληψή σας κάποιο σχετικό περιστατικό παρακαλούμε ενημερώστε μας αμέσως στο firstname.lastname@example.org|